PARSIPPANY, N.J., Oct. 11, 2016
PARSIPPANY, N.J., Oct. 11, 2016 /PRNewswire/ -- SSI Strategy has expanded its capabilities and grown its team by acquiring Scientific Advantage. Together we extend our capabilities and offer the pharma, biotech, and device industries a comprehensive array of services dedicated to Medical Affairs and Medical Science Liaisons. We provide Medical Affairs consulting and services to Life Science companies across the globe, helping them optimize strategies, enhance performance, and maximize outreach to the medical community.
With the new expertise that the Scientific Advantage team brings, SSI Strategy comprises a formidable Medical Affairs and Pharmacovigilance consulting, operations, and training firm. Collectively, the two firms have been in the Medical Affairs and Medical Liaison business for more than 15 years. Our Medical Affairs experts and experienced business consultants have supported Life Science companies in launching products and executing Medical Affairs strategies across therapeutic areas.
As the Founder of Scientific Advantage, Dr. Robin Winter-Sperry built a great team and robust Medical Affairs strategy, MSL field optimization, and scientific content development capabilities. "The addition of the Scientific Advantage team members and capabilities to our existing Medical Affairs Strategy and Operational Consulting capabilities will allow our newly expanded team to help clients achieve their objectives in new and better ways," stated Doug Locke, President of SSI Strategy.
About SSI Strategy
SSI Strategy is a boutique management-consulting firm that has designed a unique model to support scientific functions within Life Science companies. Blended teams of experienced medical experts and business consultants have the requisite knowledge to solve the industry's most complex problems and the capabilities to execute those solutions.
About Scientific Advantage
Scientific Advantage is a Medical Affairs and Medical Science Liaison company offering a suite of services from structure to strategy, including innovative Medical Affairs solutions such as Training, SOP creation/revision, Scientific Training Manuals, Content Development, and Regulatory and Compliance services. These robust capabilities are now incorporated into SSI Strategy's service offerings.
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/ssi-strategy-acquires-scientific-advantage-to-extend-its-medical-affairs-operational-strategy-and-execution-capabilities-300342061.html
SOURCE SSI StrategyPR Newswire
Last updated on: 11/10/2016
PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.